Co-Expression of IL-7 Improves NKG2D-Based CAR T Cell Therapy on Prostate Cancer by Enhancing the Expansion and Inhibiting the Apoptosis and Exhaustion

Chimeric antigen receptor (CAR) T-cell therapy is a promising approach in treating solid tumors but the therapeutic effect is limited. Prostate cancer is a typical solid malignancy with invasive property and a highly immunosuppressive microenvironment. Ligands for the NKG2D receptor are primarily ex...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Cong, Zhou, Ying, Li, Zhenlong, Farooq, Muhammad Asad, Ajmal, Iqra, Zhang, Hongmei, Zhang, Li, Tao, Lei, Yao, Jie, Du, Bing, Liu, Mingyao, Jiang, Wenzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409228/
https://www.ncbi.nlm.nih.gov/pubmed/32698361
http://dx.doi.org/10.3390/cancers12071969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409228/
https://www.ncbi.nlm.nih.gov/pubmed/32698361
http://dx.doi.org/10.3390/cancers12071969

Ejemplares similares